Clean Sweep Live Auction on Wed. May 1st. Click to view the full inventory

DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Pediatrics
Current Location:
> This Story

Log in or Register to rate this News Story
Forward Printable StoryPrint Comment




Endoscopy Homepage

The three technologies that will revolutionize minimally-invasive care The next generation of MIS techniques will be guided by familiar concepts

Fujifilm in sole-source deal with Gastrologix for all endoscopy products The manufacturer and GPO enter three-year partnership

OmniVision and Lighthouse Imaging debut platform for stereoscopic 3D endoscopy Integrates stereoscopic 3D imaging into endoscopes

Dennis Durmis MITA names chair of board of directors

NinePoint Medical's NvisionVLE AI software upgrade gets FDA nod Designed to be a great help to gastroenterologists worldwide

Body Vision gets FDA nod for its navigation catheter Works with the LungVision Imaging and Navigation System

Q&A with Dr. Camran Nezhat, the father of video endoscopy Great innovations are initially often met with skepticism

Fujifilm enters the US minimally-invasive surgery market Its new Boston-based business launched new products

New camera inspired by butterfly eyes helps surgeons remove all cancerous tissue May cost as little as $200

FDA warns duodenoscope makers about failure to comply with requirements Reprocessing issues resurface for Olympus, Fujifilm and Pentax

Olympus Medical Systems takes guilty plea deal in scope case

by Thomas Dworetzky , Contributing Reporter
Olympus Corporation subsidiary Olympus Medical Systems has reached a final plea deal with the U.S. Department of Justice over its errors filing and supplementing Medical Device Reports for its TJF-Q180V duodenoscopes concerning infections linked to the device, and to selling the device during that period.

The company, in a statement, “acknowledged that it failed to submit two required supplemental MDRs and one initial MDR” to the FDA over the problems with the devices that led to a rash of patient illnesses from 2012 to 2014, some of which proved fatal.

Story Continues Below Advertisement

Servicing GE Nuclear Medicine equipment with OEM trained engineers

We offer full service contracts, PM contracts, rapid response, time and material,camera relocation. Nuclear medicine equipment service provider since 1975. Click or call now for more information 800 96 NUMED

Olympus Medical has pleaded guilty to three criminal misdemeanors and will pay $80 million in fines and $5 million in forfeitures. In addition it will enhance how it handles regulatory affairs processes and procedures, and will make regular certifications that the company is living up to the settlement deal.

The company also stated that the investigation did not uncover “any direct harm to patients as a result of the disclosure failures,” it stated, while admitting to failure to meet federal reporting requirements.

Former Olympus senior executive Hisao Yabe also pleaded guilty to distributing misbranded devices, and could get a year in prison at his scheduled sentencing March 27, according to Reuters.

“Olympus deeply regrets its failure to file and supplement the MDRs identified in the plea agreement and accepts full responsibility for these failures,” said Hiroyuki Sasa, Olympus president and representative director.

In the years since these events occurred, Olympus has made “notable compliance improvements” addressing issues with its regulatory affairs function, including reorganizing staff and enhanced training, according to the DOJ.

Such improvement are essential as “these flexible, lighted tubes are vital for minimally-invasive, lifesaving procedures to diagnose and treat problems in the pancreas and bile duct,” said the FDA in a statement, noting, “however, because they contain many small working parts that come in contact with a patient’s bodily fluids, they must be thoroughly cleaned and disinfected between each use to prevent transmission of infections.”

The DOJ also issued a safety communications letter December 10th reporting interim results of real-world reprocessing of the devices. It advised users that best practices at present should include:

  • “Meticulously clean the elevator mechanism and the recesses surrounding the elevator mechanism by hand, even when using automated endoscope reprocessors (AERs).” It also advised raising and lowering the elevator all through a manual cleaning process to ensure that both sides get brushed and flushed. And “repeat cleaning if any soil or debris is visible.”

  •   Pages: 1 - 2 >>

Endoscopy Homepage

You Must Be Logged In To Post A Comment

Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Gold Service Dealer Program
Receive RFP/PS
Healthcare Providers
See all
HCP Tools
A Job
Parts Hunter +EasyPay
Get Parts
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Central
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2019 DOTmed.com, Inc.